Gary E. Mason
65 works · 3,672 citations · h-index 21
Top works
- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- Comprehensive Analysis of Hypermutation in Human Cancer
- Does Size Matter? Positive Predictive Value of MRI-Detected Breast Lesions as a Function of Lesion Size
- Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
- Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial
- Phase 3 MAGNITUDE study: First results of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) as first-line therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination repair (HRR) gene alterations.
- Severe cerebral edema following nivolumab treatment for pediatric glioblastoma: case report
- Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
- Pre-specified interim analysis of GALAHAD: A phase II study of niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD)
- Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance
- Quality of Life Following Amputation or Limb Preservation in Patients with Lower Extremity Bone Sarcoma
- DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells
- A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation
- Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas
- Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns
- Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study
- Mutations in the RAS/MAPK Pathway Drive Replication Repair–Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition
- Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue
- Gene-by-gene analysis in the MAGNITUDE study of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations.
- Niraparib (NIRA) with abiraterone acetate and prednisone (AAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations: Second interim analysis (IA2) of MAGNITUDE.